论文部分内容阅读
目的:总结干扰素雾化吸入合并氨溴索在慢性支气管炎急性发作中的临床疗效。方法:随机选取37例慢性支气管炎急性发作患者作对照组,仅给予干扰素雾化吸入治疗,另选取37例同种疾病患者作研究组,在对照组患者治疗基础上辅以氨溴索治疗,对比两组患者采用不同方案治疗的最终疗效。结果:研究组患者采用干扰素雾化吸入合并氨溴索治疗2周后临床症状恢复时间、总有效率均优于对照组,比较有统计学差异(P<0.05)。结论:对慢性支气管炎急性发作患者采用干扰素雾化吸入合并氨溴索治疗疗效明确,更利于疾病的尽快康复。
Objective: To summarize the clinical efficacy of inhalation of interferon combined with ambroxol in the acute episode of chronic bronchitis. Methods: Thirty-seven patients with acute exacerbation of chronic bronchitis were randomly selected as the control group, treated with inhaled interferon alone, and 37 patients with the same disease were selected as the study group. Ambroxol treatment was given to the patients in the control group , Compared the two groups of patients with different programs of treatment of the final effect. Results: The recovery time and total effective rate of clinical symptom recovery and total effective rate of study group were better than that of control group after inhalation of interferon combined with ambroxol for 2 weeks (P <0.05). Conclusion: The treatment of patients with acute exacerbation of chronic bronchitis by interferon nebulized inhalation combined with ambroxol has a clear effect and is more conducive to the rapid recovery of the disease.